An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program

Aldi T Kraja, D C Rao, Alan B Weder, Thomas H Mosley, Stephen T Turner, Chao Agnes Hsiung, Thomas Quertermous, Richard Cooper, J David Curb, Michael A Province, Aldi T Kraja, D C Rao, Alan B Weder, Thomas H Mosley, Stephen T Turner, Chao Agnes Hsiung, Thomas Quertermous, Richard Cooper, J David Curb, Michael A Province

Abstract

Background: The Family Blood Pressure Program is an ongoing, NHLBI-sponsored, multi-center program to study the genetic determinants of high blood pressure. The goal of this particular study was to study patterns of metabolic syndrome (MetS) in four ethnic groups: African Americans, Caucasians, Hispanics, and Asians.

Methods: A major part of participants in three networks GENOA, HyperGEN and SAPPHIRe were recruited mainly through hypertensive probands. MetS was defined as a categorical trait following the National Cholesterol Education Program definition (c-MetS). MetS was also characterized quantitatively through multivariate factor analyses (FA) of 10 risk variables (q-MetS). Logistic regression and frequency tables were used for studying associations among traits.

Results: Using the NCEP definition, the Hispanic sample, which by design was enriched for type 2 diabetes (T2D), had a very high prevalence of MetS (73%). In contrast, its prevalence in Chinese was the lowest (17%). In African Americans and Hispanics, c-MetS was more prevalent in women than in men. Association of c-MetS with type 2 diabetes (T2D) was prominent in the Hispanics and African Americans, less pronounced in the Whites and Japanese, (although still significant), and weakest in the Chinese sample. Using FA without rotation, we found that the main factor loaded obesity (OBS) and blood pressure (BP) in African Americans; OBS and insulin (INS) in Hispanics, in Japanese, and in Whites; and OBS alone in Chinese. In Hispanics, Whites, and Japanese, BP loaded as a separate factor. Lipids in combination with INS also loaded in a separate factor. Using FA with Varimax rotation, 4 independent factors were identified: "Obesity-INS," "Blood pressure," "Lipids-INS," and "Central obesity." They explained about 60% of the variance present in the original risk variables.

Conclusion: MetS ethnic differences were identified. Ascertaining for hypertension or T2D increased the MetS prevalence in networks compared with the one in the US general population. Obesity was the most prominent risk factor contributing to both c-MetS and q-MetS. INS contributed in two important factors (obesity and lipids). The information imbedded into c-MetS trait /q-MetS factors scores can contribute in future research of the MetS, especially its utilization in the genetic analysis.

Figures

Figure 1
Figure 1
Percent of Participants by Network and Ethnicity that Pass Thresholds per Each Risk Factor as Defined by NCEP and Percent of Participants that had 3, 4, and 5 MetS Risk Factor Combinations Beyond the NCEP Thresholds. Footnote. MS3, MS4 and MS5: three, four and five risk factors beyond the NCEP thresholds; AACo-African Americans combined; AAG-Genoa African Americans; AAH-HyperGEN African Americans; WCo-Whites combined; WG-GENOA Whites; WH-HyperGEN Whites; ACo-Asians combined; AC-Chinese Asians; AJ-Japanese Asians; His-Hispanics
Figure 2
Figure 2
Frequency of Subjects by Network Within Ethnicity Given MetS and T2D Affection Status.

References

    1. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report Circulation. 2002;106:3144–3421.
    1. Ford ES. Factor analysis and defining the metabolic syndrome. Ethn Dis. 2003;13:429–437.
    1. Choi KM, Lee J, Kim KB, Kim DR, Kim SK, Shin DH, Kim NH, Park IB, Choi DS, Baik SH, South-west Seoul Study Factor analysis of the metabolic syndrome among elderly Koreans – the South-west Seoul Study. Diabet Med. 2003;20:99–104. doi: 10.1046/j.1464-5491.2003.00890.x.
    1. Novak S, Stapleton LM, Litaker JR, Lawson KA. A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor. Diabetes Obes Metab. 2003;5:388–396. doi: 10.1046/j.1463-1326.2003.00289.x.
    1. Ramos R, Marrugat J, Basagana X, Sala J, Masia R, Elosua R, REGICOR Investigators The role of age in cardiovascular risk factor clustering in non-diabetic population free of coronary heart disease. Eur J Epidemiol. 2004;19:299–304. doi: 10.1023/B:EJEP.0000024697.55346.c2.
    1. Schutte AE, van Rooyen JM, Huisman HW, Kruger HS, de Ridder JH. Factor analysis of possible risks for hypertension in a black South African population. J Hum Hypertens. 2003;17:339–348. doi: 10.1038/sj.jhh.1001553.
    1. Shen BJ, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A, 3rd, Ward KD. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol. 2003;157:701–711. doi: 10.1093/aje/kwg045.
    1. The FBPP Investigators Multi-center genetic study of hypertension. The Family Blood Pressure Program (FBPP) Hypertension. 2002;39:3–9. doi: 10.1161/hy1201.100415.
    1. Hunt KJ, Heiss G, Sholinsky PD, Province MA. Familial history of metabolic disorders and the multiple metabolic syndrome: the NHLBI family heart study. Genet Epidemiol. 2000;19:395–409. doi: 10.1002/1098-2272(200012)19:4<395::AID-GEPI10>;2-3.
    1. S-PLUS 6 for Windows Guide to Statistics. Vol. 2. Insightful Corporation, Seattle, WA; 2003. pp. 65–82.
    1. Johnson RA, Wichern DW. Applied multivariate statistical analysis. 3-d. New Yersey; 1992. pp. 396–458.
    1. Khattree R, Naik DN. Multivariate data reduction and discrimination with SAS software. Kari, NC; 2000. pp. 111–210.
    1. Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Psychometrika. 1958;23:187–200.
    1. Kraja AT, Hunt SC, Pankow JS, Myers RH, Heiss G, Lewis CE, Rao DC, Province MA. An evaluation of the metabolic syndrome in the HyperGEN study. Nutrition & Metabolism. 2005;2:2. doi: 10.1186/1743-7075-2-2.
    1. Stokes ME, Davis CS, Koch GG. In: Categorical data analysis using the SAS system. 2-nd, editor. Cary, NC; 2000.
    1. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444–2449.
    1. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project) Am J Cardiol. 2005;95:194–198. doi: 10.1016/j.amjcard.2004.08.091.
    1. Simon PA, Zeng Z, Wold CM, Fielding JE, Burrows NR. Diabetes among Hispanics – Los Angeles County, California, 2002–2003. MMWR Morb Mortal Wkly Rep. 2003;52:1152–1155.
    1. McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans: results of a national health survey. Diabetes Care. 2004;27:66–69.
    1. Sanchez-Castillo CP, Pichardo-Ontiveros E, Lopez RP. The epidemiology of obesity. Gac Med Mex. 2004;140:S3–S20.
    1. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Hazuda HP. All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study – evidence against the "Hispanic paradox". Am J Epidemiol. 2003;158:1048–1057. doi: 10.1093/aje/kwg249.
    1. Goff DC, Nichaman MZ, Chan W, Ramsey DJ, Labarthe DR, Ortiz C. Greater incidence of hospitalized myocardial infarction among Mexican American than non-Hispanic whites. Circulation. 1997;95:1433–1440.
    1. Zhang H, Tamakoshi K, Yatsuya H, Murata C, Wada K, Otsuka R, Nagasawa N, Ishikawa M, Sugiura K, Matsushita K, Hori Y, Kondo T, Toyoshima H. Long-term body weight fluctuation is associated with metabolic syndrome independent of current body mass index among Japanese men. Circ J. 2005;69:13–18. doi: 10.1253/circj.69.13.
    1. Tan C, Ma S, Wai D, Chew S, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182–1186.
    1. Hall WD, Clark LT, Wenger NK, Wright JT, Jr, Kumanyika SK, Watson K, Horton EW, Flack JM, Ferdinand KC, Gavin JR, 3rd, Reed JW, Saunders E, O'Neal W., Jr The Metabolic Syndrome in African Americans: a review. Ethn Dis. 2003;13:414–428.
    1. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care. 2003;26:2392–2399.
    1. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation. 2003;108:1718–1723. doi: 10.1161/01.CIR.0000087597.59169.8D.

Source: PubMed

3
S'abonner